AAAAAA
Results:
1-7
|
Results: 7
Authors:
van der Laan, W
Molenaar, E
Ronday, K
Verheijen, J
Breedveld, F
Greenwald, R
Dijkmans, B
TeKoppele, J
Citation: W. Van Der Laan et al., Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial, J RHEUMATOL, 28(9), 2001, pp. 1967-1974
Authors:
Wells, G
Anderson, J
Beaton, D
Bellamy, N
Boers, M
Bombardier, C
Breedveld, F
Carr, A
Cranney, A
Dougados, M
Felson, D
Kirwan, J
Schiff, M
Shea, B
Simon, L
Smolen, J
Strand, V
Tugwell, P
van Riel, P
Welch, VA
Citation: G. Wells et al., Minimal clinically important difference module: Summary, recommendations, and research agenda, J RHEUMATOL, 28(2), 2001, pp. 452-454
Authors:
Badrising, UA
Maat-Schieman, M
van Duinen, SG
Breedveld, F
van Doorn, P
van Engelen, B
van den Hoogen, F
Hoogendijk, J
Howeler, C
de Jager, A
Jennekens, F
Koehler, P
van der Leeuw, H
de Visser, M
Verschuuren, JJ
Wintzen, AR
Citation: Ua. Badrising et al., Epidemiology of inclusion body myositis in the Netherlands: A nationwide study, NEUROLOGY, 55(9), 2000, pp. 1385-1387
Authors:
Zanelli, E
Vos, K
Breedveld, F
de Vries, R
David, C
Citation: E. Zanelli et al., Role of HLA-DQ in rheumatoid arthritis susceptibility: comment on the article by Be Vries ct al, ARTH RHEUM, 43(4), 2000, pp. 946-947
Authors:
Bresnihan, B
Tak, PP
Emery, P
Klareskog, L
Breedveld, F
Citation: B. Bresnihan et al., Synovial biopsy in arthritis research: five years of concerted European collaboration, ANN RHEUM D, 59(7), 2000, pp. 506-510
Authors:
Silman, A
Klareskog, L
Breedveld, F
Bresnihan, B
Maini, R
van Riel, P
Symmons, D
Citation: A. Silman et al., Proposal to establish a register for the long term surveillance of adverseevents in patients with rheumatic diseases exposed to biological agents: the EULAR Surveillance Register for Biological Compounds, ANN RHEUM D, 59(6), 2000, pp. 419-420
Authors:
Maini, R
St Clair, EW
Breedveld, F
Furst, D
Kalden, J
Weisman, M
Smolen, J
Emery, P
Harriman, G
Feldmann, M
Lipsky, P
Citation: R. Maini et al., Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial, LANCET, 354(9194), 1999, pp. 1932-1939
Risultati:
1-7
|